April 12, 2021
According to the recent research report titled ‘GLOBAL Neurorehabilitation Device Market 2019-2028’, available with Market Study Report, global neurorehabilitation device market is expected to register a CAGR of 14.52% during 2019-2028.
Rising pervasiveness of neurological diseases and booming elderly population are the factors primarily stimulating global neurorehabilitation device market growth. In addition, emerging neurorehabilitation wearables and robotics, along with technological advancements and escalating cases of neurological disorders are also contributing to the overall market outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552546/
Speaking of the challenges, hefty cost of the treatment, as well as lack of skilled staff to manage and treat the disorder are anticipated to negatively impact worldwide neurorehabilitation device industry share. Moreover, strict government norms are also likely to impede the business expansion.
Based on product type, the market is split into non-invasive stimulator, wearable device, brain-computer interface, neuro-robotic system, and others. With respect to application scope, global neurorehabilitation device market is categorized into multiple sclerosis, Parkinson’s disease, cerebral palsy, stroke, and others. Moving on to end user scope, the industry is bifurcated into cognitive care center, research institute, research institute, hospital/clinic, and others.
Elaborating on the geographical ambit, Asia Pacific neurorehabilitation device industry is predicted to showcase an appreciable growth over the analysis period, owing to booming elderly population, with Japan accounting for the highest number of older people in the region. Additionally, government & private organizations are introducing various initiatives to spread awareness regarding neurological conditions.
Top companies influencing global neurorehabilitation device market trends are Medtronic Inc., Esko Bionics Holdings Inc., Neurostyle Pte Ltd., Saebo Inc., Kinestica, Hokoma AG, Helis Medical Technologies, Reha Technology AG, Biometrics Ltd., Abbott Laboratories, Kinova, Ectron Ltd., BioXtreme, Tyromotion GmbH, and Bionik Laboratories Corporation.
Among these behemoths, Abbott Laboratories, operating in various nations like Japan, China, India, and Germany, is a pharmaceutical corporation that develops, manufactures, and distributes a wide range of healthcare products. The company offerings include diagnostic systems, generic pharmaceuticals, medical devices, neuromodulation devices, and pediatric and adult nutritional products.